These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 14608246)
1. Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo. Tucker P; Potter-Kimball R; Wyatt DB; Parker DE; Burgin C; Jones DE; Masters BK Psychopharmacol Bull; 2003; 37(3):135-49. PubMed ID: 14608246 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. Brady K; Pearlstein T; Asnis GM; Baker D; Rothbaum B; Sikes CR; Farfel GM JAMA; 2000 Apr; 283(14):1837-44. PubMed ID: 10770145 [TBL] [Abstract][Full Text] [Related]
3. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Davidson JR; Rothbaum BO; van der Kolk BA; Sikes CR; Farfel GM Arch Gen Psychiatry; 2001 May; 58(5):485-92. PubMed ID: 11343529 [TBL] [Abstract][Full Text] [Related]
4. Neuroimmune and cortisol changes in selective serotonin reuptake inhibitor and placebo treatment of chronic posttraumatic stress disorder. Tucker P; Ruwe WD; Masters B; Parker DE; Hossain A; Trautman RP; Wyatt DB Biol Psychiatry; 2004 Jul; 56(2):121-8. PubMed ID: 15231444 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of Prolonged Exposure Therapy, Sertraline Hydrochloride, and Their Combination Among Combat Veterans With Posttraumatic Stress Disorder: A Randomized Clinical Trial. Rauch SAM; Kim HM; Powell C; Tuerk PW; Simon NM; Acierno R; Allard CB; Norman SB; Venners MR; Rothbaum BO; Stein MB; Porter K; Martis B; King AP; Liberzon I; Phan KL; Hoge CW JAMA Psychiatry; 2019 Feb; 76(2):117-126. PubMed ID: 30516797 [TBL] [Abstract][Full Text] [Related]
6. Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline. Stahl SM Biol Psychiatry; 2000 Nov; 48(9):894-901. PubMed ID: 11074227 [TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder. Panahi Y; Moghaddam BR; Sahebkar A; Nazari MA; Beiraghdar F; Karami G; Saadat AR Psychol Med; 2011 Oct; 41(10):2159-66. PubMed ID: 21349225 [TBL] [Abstract][Full Text] [Related]
9. Baclofen add-on to citalopram in treatment of posttraumatic stress disorder. Manteghi AA; Hebrani P; Mortezania M; Haghighi MB; Javanbakht A J Clin Psychopharmacol; 2014 Apr; 34(2):240-3. PubMed ID: 24525635 [TBL] [Abstract][Full Text] [Related]
10. Open-label trial of escitalopram in the treatment of posttraumatic stress disorder. Robert S; Hamner MB; Ulmer HG; Lorberbaum JP; Durkalski VL J Clin Psychiatry; 2006 Oct; 67(10):1522-6. PubMed ID: 17107242 [TBL] [Abstract][Full Text] [Related]
11. Faster onset of antidepressant effects of citalopram compared with sertraline in drug-naïve first-episode major depressive disorder in a Chinese population: a 6-week double-blind, randomized comparative study. Hsu JW; Su TP; Huang CY; Chen YS; Chou YH J Clin Psychopharmacol; 2011 Oct; 31(5):577-81. PubMed ID: 21869697 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study. Davidson J; Pearlstein T; Londborg P; Brady KT; Rothbaum B; Bell J; Maddock R; Hegel MT; Farfel G Am J Psychiatry; 2001 Dec; 158(12):1974-81. PubMed ID: 11729012 [TBL] [Abstract][Full Text] [Related]
13. Sertraline treatment of children and adolescents with posttraumatic stress disorder: a double-blind, placebo-controlled trial. Robb AS; Cueva JE; Sporn J; Yang R; Vanderburg DG J Child Adolesc Psychopharmacol; 2010 Dec; 20(6):463-71. PubMed ID: 21186964 [TBL] [Abstract][Full Text] [Related]
14. Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment. Rapaport MH; Endicott J; Clary CM J Clin Psychiatry; 2002 Jan; 63(1):59-65. PubMed ID: 11838628 [TBL] [Abstract][Full Text] [Related]
15. Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram. Mullins CD; Shaya FT; Meng F; Wang J; Harrison D Pharmacotherapy; 2005 May; 25(5):660-7. PubMed ID: 15899727 [TBL] [Abstract][Full Text] [Related]